In the first trial (n=598) relative risk (RR) for death with early fluid administration was 1.26 (95% confidence interval of 1.00−1.58). The weighted mean differences (WMD) for prothrombin time and partial thromboplastin time were 2.7 (95% CI 0.9−4.5) and 4.3 (95% CI 1.74−6.9) seconds respectively.
In the second trial (n=50) RR for death with early blood transfusion was 5.4 (95% CI 0.3−107.1). The WMD for partial thromboplastin time was 7.0 (95% CI 6.0−8.0) seconds. In the third trial (n=1309) RR for death with early fluid administration was 1.06 (95% CI 0.77−1.47).
Larger versus smaller volume of fluid administration
Three trials reported mortality and one coagulation data.
In the first trial (n=36) RR for death with a larger volume of fluid resuscitation was 0.80 (95% CI 0.28−22.29). Prothrombin time and partial thromboplastin time were 14.8 and 47.3 seconds in those who received a larger volume of fluid, as compared to 13.9 and 35.1 seconds in the comparison group.
In the second trial (n=110) RR for death with a high systolic blood pressure resuscitation target (100mmHg) maintained with a larger volume of fluid, as compared to low systolic blood pressure resuscitation target (70mmHg) maintained with a smaller volume of fluid was 1.00 (95% CI 0.26−3.81). In the third trial (n=25) there were no deaths.
Authors' conclusions
We found no evidence from randomised controlled trials for or against early or larger volume of intravenous fluid administration in uncontrolled haemorrhage. There is continuing uncertainty about the best fluid administration strategy in bleeding trauma patients. Further randomised controlled trials are needed to establish the most effective fluid resuscitation strategy.
P L A I N L A N G U A G E S U M M A R Y

No evidence from trials to support or not to support the use of early or larger volume intravenous fluid in uncontrolled bleeding
About one third of injury deaths are due to shock from blood loss. Preventing shock in people with uncontrolled bleeding is, therefore, very important and is generally done by giving fluids intravenously. The aim is to maintain blood pressure and reduce tissue damage. The review of trials found that there is uncertainty about the best time to give fluid and what volume of fluid should be given. While increasing fluids will maintain blood pressure, it may also worsen bleeding by diluting clotting factors in the blood. More research is needed.
B A C K G R O U N D
In 1990 approximately five million people died worldwide as a result of injury (Murray 1996) . For people younger than 35 years, injury is now the leading cause of death. Nevertheless, the global epidemic of injury is only beginning. It is estimated that by 2020, deaths from injury will have increased from 5.1 million to 8.4 million (Murray 1997) . About one third of injury deaths are due to haemorrhagic shock (Deakin 1994) . Acute blood loss following injury leads to a reduction in tissue perfusion and tissue oxygen delivery that, if prolonged, causes lactic acidosis and organ failure. Treatment of haemorrhagic shock involves maintaining blood pressure and tissue perfusion until the bleeding is controlled. Over the past 50 years, a number of resuscitation strategies have been used to maintain the blood pressure in trauma patients until bleeding is controlled. The evidence for the effectiveness of these approaches has been the subject of a number of systematic reviews by the Cochrane Injuries Group and by others.
Pre-hospital use of medical anti-shock trousers
Medical anti-shock trousers (MAST) were first used in the Vietnam War to stabilise patients with haemorrhagic shock during transportation. After the war, MAST became widely used in the care of bleeding trauma patients. MAST increases blood pressure by compressing the blood vessels in the legs, thus increasing systemic vascular resistance, and by shunting blood from the lower body to the brain, heart and lungs. It was hoped that by increasing venous return to the heart, MAST would maintain blood flow to vital organs until definitive care was given. Nevertheless, a systematic review of randomised controlled trials of MAST use in prehospital trauma care provided no evidence that MAST increases survival, and a suggestion that it may increase the risk of death. The pooled relative risk of death with MAST was 1.13 (95% CI 0.97−1.32) (Dickinson 1999).
Paramedic ambulance crews
In high-income countries, an increasing number of ambulance crews include a paramedic trained in advance life support. Paramedics receive extra training in intubation, intravenous cannulation, and the administration of intravenous fluids. Only a small proportion of paramedic-attended trauma patients require intubation (1%), but a larger proportion (18%) receive intravenous fluids (Nicholl 1998). Because of the strong conviction amongst the public and medical profession that paramedic intervention is beneficial, it has been difficult to conduct randomised controlled trials comparing paramedic and non-paramedic trauma care. However, a review and meta-analysis of four cohort studies gave a significantly increased (p=0.03) risk of death in paramedic attended patients (RR=1.26) (Nicholl 1998) . Because of the potential for confounding by injury severity, the validity of inferences from cohort studies must be questioned. Nevertheless, the results are consistent with the hypothesis that efforts by paramedics to raise the blood pressure of bleeding trauma patients may be counterproductive.
Colloid fluid resuscitation
Intravenous fluid administration, with colloid or crystalloid solutions, is the mainstay of the non-surgical management of bleeding trauma patients. Colloids are better than crystalloid solutions in expanding the circulation, because they are retained within the blood vessels to a greater extent. Crystalloid solutions rapidly leak out of the blood vessels into the interstitial spaces. After a colloid infusion, the increase in the circulating volume is about the same as the volume of colloid infused, whereas only about one quarter of the volume of a crystalloid infusion remains in the blood vessels (Weil 1999) . Although colloids are effective in expanding the circulation there is no evidence that this improves outcome in critically ill patients (Alderson 2000) .
The systematic reviews of medical anti-shock trousers, paramedic resuscitation and colloid administration call into question the benefits of raising the blood pressure in bleeding trauma patients. But by what mechanisms could fluid resuscitation adversely affect outcome? Stern, using a swine model of near-fatal haemorrhage, found that attempts to restore blood pressure with crystalloid resulted in increased haemorrhage volume and markedly higher mortality ( Stern 1993). It was postulated that the increased pulse pressure from crystalloid resuscitation might cause the mechanical disruption of blood clots and worsen bleeding. It has also been proposed that fluid administration might also worsen bleeding by diluting clotting factors. In view of the concerns raised by the previous systematic reviews and by the results of animal models of haemorrhagic hypovolaemia, we have conducted a systematic review of the effect on mortality of early versus delayed fluid resuscitation, and of larger versus smaller fluid volumes.
O B J E C T I V E S
To examine the effect on mortality and coagulation times of two intravenous fluid administration strategies in the management of haemorrhagic hypovolaemia: early compared to delayed administration and larger compared to smaller volume of fluid administered.
M E T H O D S Criteria for considering studies for this review
Types of studies
All unconfounded randomised and quasi-randomised controlled trials of the timing or volume of intravenous fluid administration in haemorrhagic hypovolaemia.
Types of participants
Patients of all ages with haemorrhagic hypovolaemia of traumatic or non-traumatic origin. Because the physiological response to bleeding and to fluid resuscitation is likely to be similar among patients with internal bleeding (e.g. bleeding peptic ulcer) and those with external bleeding (e.g. penetrating trauma), both types of participants were included.
Types of interventions
Intravenous fluids including crystalloid solutions, colloids, plasma and blood. Trials in which the timing or volume of fluid administration is confounded by the type of intravenous fluid given − for example, a trial comparing the administration of 1000ml of colloid with 500ml blood − were excluded.
Types of outcome measures
Mortality from all causes at the end of the follow-up period scheduled for each trial. We sought mortality data in simple categorical form, and we did not extract data on time to death. If a report did not include the numbers of deaths in each group, we sought these data from the authors. We also sought data on prothrombin time and partial thromboplastin time during fluid administration.
Search methods for identification of studies
Searches were not restricted language, date or publication status.
Electronic searches
We searched: The search strategy can be found in Appendix 1.
Searching other resources
We checked the reference lists of all included studies and contacted authors and experts in the field. The Science Citation Index was checked for eligible papers that cited two of the trials (Bickell 1994 , Blair 1986 included in this review.
Data collection and analysis
Selection of studies
One reviewer (IK) examined the electronic search results for reports of possibly relevant trials and these reports were then retrieved in full. The first reviewer (IK) also contacted experts in the field for unpublished and ongoing trials. A second reviewer (FB) examined 10% of the electronic search results to check for agreement on eligibility criteria. Two reviewers (FB, IK) applied the selection criteria independently to the trial reports, resolving disagreements by discussion with a third (IR).
Data extraction and management
Two reviewers (IK, FB) independently extracted information on the following: method of allocation concealment, number of randomised patients, type of participants and the interventions, loss to follow-up and length of follow-up. The outcome data sought were numbers of deaths, prothrombin time and partial thromboplastin time. The reviewers were not blinded to the authors or journal when doing this. Results were compared and any differences resolved by discussion.
Where there was insufficient information in the published report we attempted to contact the authors for clarification.
Assessment of risk of bias in included studies
Since there is evidence that the quality of allocation concealment particularly affects the results of studies, two reviewers (IK, FB) scored this quality on the scale used by Higgins 2008 as shown below, assigning 'No' to poorest quality and 'Yes' to best quality:
• Yes = trials deemed to have taken adequate measures to conceal allocation (i.e. central randomisation; serially numbered, opaque, sealed envelopes; or other description that contained elements convincing of concealment)
• Unclear = trials in which the authors either did not report an allocation concealment approach at all or reported an approach that did not fall into one of the other categories
• No = trials in which concealment was inadequate (such as alternation or reference to case record numbers or to dates of birth).
Where the method used to conceal allocation was not clearly reported, the author(s) were contacted, if possible, for clarification. We then compared the scores allocated and resolved differences by discussion.
Data synthesis
The following comparisons were made:
• early versus delayed intravenous fluids administration • larger versus smaller volume of intravenous fluids administration.
The relative risk of death and 95% confidence interval (95% CI) was calculated, such that a relative risk of more than 1 indicated a higher risk of death in the first group named. The relative risk was chosen as it is more readily applied to the clinical situation. The weighted mean difference was calculated for coagulation times. Because of differences in the types of patients and in the nature of the trial interventions we did not pool the data in our analysis.
R E S U L T S Description of studies
See: Characteristics of included studies. Our original search strategy found 4,487 potentially eligible reports of which six unpublished trials met the inclusion criteria. A further 655 abstracts were retrieved from a search carried out in August 2007, and another search in October 2008 retrieved 261 abstracts. All search results were scanned by two individuals for potentially relevant studies. No new trials that met the inclusion criteria were indentified from these search results.
A. Early versus delayed intravenous fluids administration
Bickell 1994
This trial compared early versus delayed administration of Ringer's acetate solution, an isotonic crystalloid, in patients with penetrating torso injuries during the prehospital phase. Participants were adults over 16 years of age, with gunshot or stab wounds to the torso, and who had a systolic blood pressure of <90mmHg. Participants with head injury, a Revised Trauma Score of zero or minor injuries were excluded. During the trial, 22 patients (8%) in the delayed resuscitation group were inadvertently given fluid prior to surgery in violation of the protocol. Follow-up was until hospital discharge. Blair 1986 This trial compared early versus delayed blood transfusion in patients with acute gastrointestinal haemorrhage during the first 24 hours after admission. Patients with oesophageal varices were excluded because of abnormal coagulation related to liver diseases. Follow-up was until hospital discharge. Turner 2000 This trial compared early versus no/delayed fluid administration in trauma patients. Participants were all trauma patients with moderate to severe injuries, over the age of 16 years of age. Patients who were pregnant or without vital signs were excluded. Fluids given were crystalloids. Protocol compliance was poor with 31% of patients in the early fluid group receiving fluids and 80% of the delayed/no fluid group not given fluids. Follow-up was for six months.
B. Larger versus smaller volume of intravenous fluids administration
Dunham 1991
This trial compared fluid resuscitation using the rapid infusion system and conventional fluid administration method in trauma patients during the first 24 hours of admission. Participants were between 14 and 60 years of age and had a systolic blood pressure of <90mmHg. Patients with a Glasgow Coma Score of <5, cardiac arrest, quadriplegia and myocardial infarct on admission were excluded. Fluids given included red blood cells, platelets, fresh frozen plasma and crystalloids. Follow-up was until hospital discharge.
Dutton 2002
This trial compared the maintenance of target systolic blood pressures of 70 and 100mmHg respectively with fluid restriction (Plasma, Plasmalyte-A and red blood cells in the first 24 hours) in patients with blunt and penetrating trauma injuries. All participants suffered haemorrhagic shock with a systolic blood pressure (SBP) of <90mmHg. Patients with head or spinal cord injury were excluded. Length of follow-up period was until death or hospital discharge. Fortune 1987 This trial compared the maintenance of haematocrit at 30% and 40% respectively with blood transfusion in patients following acute injuries and haemorrhage during the first 72 hours of admission. All participants had sustained Class III/IV haemorrhage with a systolic blood pressure of <90mmHg, heart rate > 100 beats per minute. Follow-up was for three days.
Risk of bias in included studies
A. Early versus delayed intravenous fluids administration
Bickell 1994
Randomisation was by alternate day allocation which allowed foreknowledge of treatment allocation. Data were analysed as randomised, on an intention-to-treat basis. Blinding of outcome assessment was not stated. There was no loss to follow-up. Blair 1986 Contact with the author of this trial established the adequacy of the randomisation method used. Allocation was by opening sealed envelopes at the time of patient presentation. Blinding of outcome assessment was not stated. Data were analysed as randomised, on an intention-to-treat basis. There was no loss to follow-up. Turner 2000 Paramedics rather than trauma patients were randomised, using computer-generated random numbers, stratified by base stations. The paramedics crossed over to alternate fluid protocol halfway through the trial and they were not blinded. Data were analysed as randomised, on an intention-to-treat basis. There was no blinding in outcome assessment.
B. Larger versus smaller volume of intravenous fluids administration
Dunham 1991
Method of randomisation and allocation concealment was unclear. Blinding of outcome assessment was not stated. Data on eight patients who died during the first 12 hours were excluded from the analysis except for the outcome of death. Dutton 2002 Randomisation was by selecting the next numbered envelope from a supply maintained in the Trauma Resuscitation Unit. The envelopes were made up in batches of 20 (10 to each group), thoroughly mixed, and then numbered for selection. Allocation was blinded to all Unit personnel prior to enrolment . Only the patients were blinded to the allocation in this trial after randomisation. Data were analysed as randomised, on an intention-to-treat basis. Blinding of outcome assessment was not stated. There was no loss to follow-up. Fortune 1987 Contact with the co-author of this trial established the adequacy of the randomisation method used. Sequences of random allocations were generated by a statistician not involved with the study, in sets of sealed opaque envelopes, differentiated by sex and age groups. Both patients and physicians had no prior knowledge of which arm the patient would be assigned to. Blinding of outcome assessment was not stated. There was no loss to follow-up. The characteristics of each trial are listed in Characteristics of included studies.
Effects of interventions A. Early versus delayed fluid administration
One trial (Bickell 1994) reported mortality and coagulation time on a total of 598 hypotensive trauma patients with penetrating torso injuries. Mortality was 116/309 (38%) in the early and 86/289 (30%) in the delayed administration group. The relative risk for death with early fluid administration was 1.26 (95% CI 1.00−1.58). Prothrombin time and partial thromboplastin time were 14.1 and 31.8 seconds in the early, as compared to 11.4 and 27.5 seconds in the delayed administration group. The weighted mean difference (WMD) for prothrombin time and partial thromboplastin time was 2.7 (95% CI 0.90−4.5) and 4.3 seconds (95% CI 1.7−6.9) respectively. One trial (Blair 1986) reported mortality and coagulation time on a total of 50 hypotensive patients with acute upper gastrointestinal haemorrhage. Mortality was 2/24 (8%) in the early as compared to 0/26 (0%) in the delayed transfused group. The relative risk for death with early blood transfusion was 5.4 (95% CI 0.3−107.1). Activated partial thromboplastin time was 48 in the early, as compared to 41 seconds in the delayed administration group. The WMD for partial thromboplastin time was 7.0 seconds (95% CI 6.0−8.0). In one trial (Turner 2000) on a total of 1309 trauma patients, mortality was 73/699 (10.4%) in the early as compared to 60/610 (9.8%) in the delayed/no fluid administration group. The relative risk for death with early fluid administration was 1.06 (95% CI 0.77−1.47). There were no data on coagulation times.
B. Larger versus smaller volume of fluid administration
One trial (Dunham 1991) reported mortality and coagulation time on a total of 36 hypotensive trauma patients. Mortality was 5/20 (25%) in the group who received a larger volume of fluids administered conventionally, as compared to 5/16 (31%) in the group who received a smaller volume of fluids administered using the Rapid Infusion System. The relative risk for death is 0.80 (95% CI 0.28−2.29). Prothrombin time and partial thromboplastin time were 14.8 and 47.3 seconds in the group who received a larger volume of fluid as compared to 13.9 and 35.1 seconds in the comparison group. In one trial (Dutton 2002) on a total of 110 hypotensive patients with blunt and penetrating injuries, mortality was 4/55 (7.3%) in the group administered a larger volume and 4/55 (7.3%) in the group administered a smaller volume (1000ml less than in the intervention group). The relative risk for death is 1.00 (95% CI 0.26−3.81). There were no data on coagulation times. In one trial (Fortune 1987) on a total of 25 hypotensive patients with acute injury and haemorrhage, there were no data on mortality in both the groups administered with larger or smaller volume of blood. Contact with the co-author established that there were no deaths in either group. There were no data on coagulation times.
D I S C U S S I O N
This review found insufficient evidence for or against the use of early or larger volume fluid resuscitation in the treatment of uncontrolled haemorrhage. While vigorous fluid resuscitation may be life-saving in some patients, results from clinical trials are inconclusive.
Every year, tens of thousands of patients receive intravenous fluids in the management of bleeding. The Advanced Trauma Life Support (ATLS) protocol of the American College of Surgeons recommends the liberal use of isotonic crystalloid to correct hypotension in bleeding trauma patients. Nevertheless, we could find no reliable evidence to support or not to support this recommendation. While we cannot exclude the possibility that we overlooked a large high-quality randomised controlled trial showing that early or larger volume fluid resuscitation is beneficial, we believe that this is unlikely. To identify eligible trials we screened over 4,000 potentially relevant reports, we searched the reference lists of included trials, and contacted authors and experts in the field.
Six published trials were reviewed. Due to their heterogeneity, in terms of types of patients and types of fluids used, we did not attempt to perform a meta-analysis of the studies.
Death was chosen as the primary end-point in this review for two reasons. First, death is a clinically relevant outcome that matters to patients. Second, death is not prone to measurement error and to reporting bias, as are pathophysiological end points. Mortality data were available for all six included trials, three on the effect of early fluid resuscitation (Bickell 1994; Blair 1986; Turner 2000) and three on the effect of larger volume fluid resuscitation (Dunham 1991 , Dutton 2002 , Fortune 1987 .Three trials examined the effect of fluid administration on coagulation. Clotting times were significantly elevated in the immediate resuscitation groups (Bickell 1994 , Blair 1986 ) and the group who received a larger volume (Dunham 1991). Method of randomisation was inadequate in two trials (Bickell 1994 , Turner 2000 and unclear in another (Dunham 1991) . Allocation concealment was inadequate in two trials (Bickell 1994; Turner 2000) . Because inadequate randomisation and poorly concealed allocation can bias the results of randomised controlled trials, and because this bias can be large and can operate in either direction, the impact of early or larger volume fluid resuscitation on mortality remains difficult to estimate.
Interpretation of results also needs to be cautious due to the heterogeneous nature of traumatic injuries encountered in these trials. Haemorrhagic shock can be caused by a variety of underlying anatomic injuries. Some of these injuries, such as posterior pelvic fractures, may be more amenable to hypotensive management maintained by smaller volume of fluid, than liver injuries where haemostasis can be difficult to achieve (Dutton 2002) .
The use of medical anti-shock trousers, early and larger volume fluid administration and colloid resuscitation are based on the idea that raising the blood pressure in bleeding trauma patients will maintain tissue perfusion and so prevent haemorrhagic shock and its consequences. However, while maintaining blood pressure may prevent shock, it may worsen bleeding. In view of the lack of evidence for or against the effectiveness of currently recommended resuscitation protocols and the potential for harm, the balance of risks and benefits of contemporary resuscitation practice warrants careful consideration. Further randomised controlled trials are required to identify the most effective strategies for the fluid management of bleeding trauma patients.
A U T H O R S ' C O N C L U S I O N S Implications for practice
We found no evidence for or against the use of early or larger volume intravenous fluid administration in uncontrolled haemorrhage. There is uncertainty about the effectiveness of fluid resuscitation in patients with bleeding following trauma.
Implications for research
Large, well concealed, randomised controlled trials are urgently needed to establish the optimal fluid resuscitation strategy in haemorrhaging trauma patients, with a focus on specific types of injuries likely to benefit from the appropriate resuscitation strategy in terms of timing and volume of fluids given.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bickell 1994
Methods Quasi-randomised controlled trial.
(Allocation by alternation -odd and even numbered days of the month.)
Participants 598 trauma patients >16 years of age with penetrating injuries and hypotension. Mean age = 31 years. Exclusion: pregnancy, Revised Trauma Score = 0, minor injuries not requiring surgery.
Interventions 1) 870ml of Ringer's solution pre-hospital (n=309).
2) 92ml of Ringer's solution with IV cannulation pre-hospital (n=289).
Outcomes
• Haemodynamic variables,
• amount of fluids given,
• intraoperative blood loss,
• process of care, • death.
Notes
Patients in both groups were treated with a standard paramedical protocol as appropriate until after IV cannulation. 22/289(8%) in delayed fluids group were inadvertently given fluids in violation of the protocol. Results were analysed as randomised on an intention-to-treat basis. 
Risk of bias
Item
External sources
• Global Programme on Evidence for Health Policy (GPE), World Health Organisation, Switzerland. 
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